Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
| ▸ | RARB | P10826 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | PLK1 | P53350 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18323068 | 0.90 | APP (0.48) | GAANR1I2CYP3A4SMN1; SMN2L3MBTL1 | |
| SCHEMBL36443 | 0.88 | GAA (0.56) | GAANR1I2CYP3A4SMN1; SMN2L3MBTL1 | |
| SCHEMBL27025553 | 0.88 | GAA (0.56) | GAANR1I2CYP3A4SMN1; SMN2L3MBTL1 | |
| SCHEMBL17921592 | 0.88 | GAA (0.56) | GAANR1I2CYP3A4SMN1; SMN2L3MBTL1 | |
| Lithium SCHEMBL30864217 | 0.86 | GAA (0.54) | GAANR1I2CYP3A4SMN1; SMN2L3MBTL1 | |
| SCHEMBL10005221 | 0.86 | GAA (0.54) | GAANR1I2CYP3A4SMN1; SMN2L3MBTL1 | |
| SCHEMBL31556323 | 0.86 | GAA (0.58) | GAANR1I2CYP3A4SMN1; SMN2L3MBTL1 | |
| SCHEMBL28651564 | 0.86 | GAA (0.54) | GAANR1I2CYP3A4SMN1; SMN2L3MBTL1 | |
| SCHEMBL10029313 | 0.86 | L3MBTL1 (0.60) | GAAL3MBTL1MAPTALDH1A1TP53 | |
| SCHEMBL18317956 | 0.85 | GAA (0.53) | GAANR1I2CYP3A4SMN1; SMN2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3770181-A1 | METHOD FOR PREPARING HYALURONIC ACID HYDROGEL MIROPARTICLES AND USE THEREOF IN REPAIRING ARTICULAR CARTILAGE DEFECTS | Kaohsiung Medical University (TW) | 2021-01-27 | — | — | EP | claimed |
| US-20210015967-A1 | METHOD FOR PREPARING HYALURONIC ACID HYDROGEL MICROPARTICLES AND USE THEREOF IN REPAIRING ARTICULAR CARTILAGE DEFECTS | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2021-01-21 | — | — | US | claimed |
| WO-2019178825-A1 | METHOD FOR PREPARING HYALURONIC ACID HYDROGEL MIROPARTICLES AND USE THEREOF IN REPAIRING ARTICULAR CARTILAGE DEFECTS | 高雄医学大学 | 2019-09-26 | — | — | WO | claimed |
| US-20110301525-A1 | BIOMATERIALS FOR TISSUE REPLACEMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2011-12-08 | — | — | US | claimed |
| US-20110189253-A1 | BIOMATERIAL COMPOSITION AND METHOD | WARSAW ORTHOPEDIC, INC. (US) | 2011-08-04 | — | — | US | claimed |
| US-20110182957-A1 | CELLULOSICS FOR TISSUE REPLACEMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2011-07-28 | — | — | US | claimed |
| WO-2010056899-A1 | BIOMATERIALS FOR TISSUE REPLACEMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-05-20 | — | — | WO | claimed |
| WO-2009155583-A1 | BIOMATERIALS FOR TISSUE REPLACEMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-12-23 | — | — | WO | claimed |
| US-12341195-B2 | Conducting polymer network-protected phosphorus anode active material for lithium-ion or sodium-ion batteries | HONEYCOMB BATTERY COMPANY (US) | 2025-06-24 | — | — | US | disclosed |
| US-12230790-B2 | Method of producing conducting polymer network-enabled particulates of anode active material particles for lithium-ion batteries | HONEYCOMB BATTERY COMPANY (US) | 2025-02-18 | — | — | US | disclosed |
| US-20240363867-A1 | CONDUCTING POLYMER NETWORK-PROTECTED CATHODE ACTIVE MATERIALS FOR LITHIUM SECONDARY BATTERIES | HONEYCOMB BATTERY COMPANY (US) | 2024-10-31 | — | — | US | disclosed |
| US-12036078-B2 | Oral products and methods for producing the same | PolySpectra, Inc. (US) | 2024-07-16 | — | — | US | disclosed |
| US-12009505-B2 | Conducting polymer network/graphene-protected negative electrode for a lithium-ion battery | HONEYCOMB BATTERY COMPANY (US) | 2024-06-11 | — | — | US | disclosed |
| CN-117982423-A | Lipid-hydrogel composite drug delivery system and preparation method thereof | 中国科学院香港创新研究院再生医学与健康创新中心有限公司 | 2024-05-07 | — | — | CN | disclosed |
| WO-2009155583-A1 | BIOMATERIALS FOR TISSUE REPLACEMENT | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2009-12-23 | — | — | WO | disclosed |
| US-20090062418-A1 | NOVEL PHOTOINITIATORS | XEROX CORPORATION (US) | 2009-03-05 | — | — | US | disclosed |
| WO-2008144514-A2 | POLYOL-BASED POLYMERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-11-27 | — | — | WO | disclosed |
| US-7455891-B2 | Process for the production of strongly adherent coatings | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2008-11-25 | — | — | US | disclosed |
| US-20070122392-A1 | Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2007-05-31 | — | — | US | disclosed |
| WO-2007002664-A2 | PROPAGATION OF UNDIFFERENTIATED EMBRYONIC STEM CELLS IN HYALURONIC ACID HYDROGEL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2007-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110301525-A1 | BIOMATERIALS FOR TISSUE REPLACEMENT | PLOD3, CUTA, PLOD2 | GAA 794/4885NR1I2 4790/4885CYP3A4 3530/4885 |
| US-20110182957-A1 | CELLULOSICS FOR TISSUE REPLACEMENT | CUTA, PLOD2, LIPG | GAA 481/4885NR1I2 4858/4885CYP3A4 3476/4885 |
| US-20090062418-A1 | NOVEL PHOTOINITIATORS | PPOX, FTO, CBR3 | GAA 4401/4885NR1I2 131/4885CYP3A4 150/4885 |
| US-20110189253-A1 | BIOMATERIAL COMPOSITION AND METHOD | ILK, KIT, CAD | GAA 4159/4885NR1I2 4700/4885CYP3A4 4312/4885 |
| US-12036078-B2 | Oral products and methods for producing the same | CROCC, RPAP1, RUVBL1 | GAA 1468/4885NR1I2 432/4885CYP3A4 962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.